Latest


Lupin gets FDA nod for Mycobutin generic version

  •   Wed, Feb 26 2014 07:41:41 PM

New Delhi, Feb 26 (IANS): Drug maker Lupin Wednesday said it has received final approval from the US health regulator to market the generic version of Mycobutin capsules of Pharmacia and Upjohn Company used in treating advance HIV infection.

The approval from the US Food and Drug Administration is for Rifabutin Capsules USP, in strength of 150 mg, said Lupin in a statement.

According to IMS Mat, Mycobutin Capsules had annual sales of $18.6 million in the US.

  

Top Stories

International Clown Festival in Mangaluru from October 4-6

  •   1 hour ago   

Leave a Comment

Title: Lupin gets FDA nod for Mycobutin generic version



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.

You might also like